In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Cardiology Update 2015, Davos, Switzerland

an ESC Update Programme

Add to calendar09/02/20150:00 12/02/20150:00 Europe/Paris Cardiology Update 2015, Davos, Switzerland European Society of Cardiology true DD/MM/YYYY

Monday, 9 February 2015

Social value and meaningful outcomes in clinical trials research     S. Pocock, London (UK)
Value of fixed combination treatments in hypertensive patients with comorbidities     J.-J. Mourad, Paris (FR)
Environmental hazards – air pollution and noise as novel risk factors     T. Gori, Mainz (DE)
Recommendations for sports participation in athletes with known cardiovascular disease     D. Corrado, Padov (IT)

“Paracelsus reloaded” – searching for the perfect “dose” of physical activity     S. Sharma, London (UK)
Bariatric surgery in obesity and type 2 diabetes     E. Osto, Zurich (CH)
NOACs in AF patients undergoing cardioversion: Overview and latest data     A.J. Camm, London (UK)

Tuesday, 10 February 2015

HDL-Cholesterol – an enigma?     U. Landmesser, Berlin (DE)
Heart rate reduction in angina and heart failure: a paradox?     K. Swedberg, Gothenburg (SE)
Differential imaging: How to select the right tool for the patient’s problem?     J.J. Bax, Leiden (NL)
Hybrid imaging     O. Gämperli, Zurich (CH)
Diagnosis of thrombosis and pulmonary embolism     H. Bounameaux, Geneva (CH)
ESC Guidelines on pulmonary embolism: recommendations and patient management     A. Torbicki, Warszawa (PL)
Thrombosis and Pulmonary Embolism: Implementing the New Guidelines - Cases:  A. Torbicki, Warszawa (PL)
Ablation of Ventricular Tachycardias: When and How? - Cases: L. Haegeli, Zurich (CH)    
Ventricular tachycardia: drugs versus devices     A.J. Camm, London (UK)
Role of catheter ablation for the management of VT     H. Calkins, Baltimore (US)
Pathophysiology of PH – the right heart matters     R. Naeije, Brussels (BE)
Therapeutic approaches in PH and the new ESC Guidelines     J.-L. Vachiery, Brussels (BE)
Medical management of cardiac patients during non-cardiac surgery     D. Spahn, Zurich (CH)

Wednesday, 11 February 2015

Critical appraisal of AF management guidelines across the Atlantic     H. Calkins, Baltimore (US)
Curative treatment of AF: too far to reach?     G. Hindricks, Leipzig (DE)
Risk stratification in the elderly with AF: therapeutic implications     D. Atar, Oslo (NO)
Genetics of cardiomyopathies     P. Elliott, London (UK)
The new ESC Guidelines on hypertrophic cardiomyopathy     P. Elliott, London (UK)
Is FFR essential to guide PCI?     W. Wijns, Aalst (NL)
Cardiomyopathies, sudden death -Cases: C. Gruner, Zurich (CH)
What is a Significant Coronary Stenosis? Coronary Flow and Pressure Measurement as a Guide - Cases: K. Weber, Winterthur     
The role of imaging in catheter-based procedures     J.J. Bax, Leiden (NL)
Early diagnosis of acute MI: novel strategies     C. Müller, Basel (CH)
Mechanisms of ACS: the clinical perspective     F. Crea, Rome (IT)
Update on prasugrel – optimising therapy after ACS/PCI     C. Kaiser, Basel (CH)

Thursday, 12 February 2015

Sleep apnoea and heart failure     P. Ponikowski, Wroclaw (PL)
Telemonitoring in heart failure: IN-TIME and beyond     G. Hindricks, Leipzig (DE)
Devices in Heart Failure - Cases: E. Holy, Zurich  (CH)    
Early management of acute HF: Time is also muscle     G. Filippatos, Athens (GR)


Zurich Heart House
Foundation for Cardiovascular Research
Moussonstrasse 4, CH-8091 Zurich, Switzerland
Phone +41 (0) 44 250 40 83, Fax +41 (0) 44 250 40 90 
Esther Willi (

Programme Directors

Thomas F. Lüscher, Zurich, CH
Bertram Pitt, Ann Arbor MI, USA

Scientific Coordinator

Ruth Amstein, Zurich, CH

Programme Committee

Ruth Amstein, Ph.D., Zurich, CH
Jeroen J. Bax, M.D., Leiden, NL
Paolo G. Camici, M.D., Milan, IT
Filippo Crea, M.D., Rome, IT
Thierry C. Gillebert, M.D., Gent, BE
John J.P. Kastelein, M.D., Amsterdam, NL
Michel Komajda, M.D., Paris, FR
Thomas F. Lüscher, M.D., Zurich, CH
Bernhard Meier, M.D., Berne, CH
Bertram Pitt, M.D., Ann Arbor, MI, USA
Karl Swedberg, M.D., Gothenburg, SE
William Wijns, M.D., Ph.D., Aalst, BE
Salim Yusuf, M.D., Hamilton, Ontario, CA

Local Programme Committee

Corinna Brunckhorst, M.D., Zurich, CH
Roberto Corti, M.D., Zurich, CH
Firat Duru, M.D., Zurich, CH
Volkmar Falk, M.D., Zurich, CH
Matthias Greutmann, M.D., Zurich, CH
Johannes Holzmeister, M.D., Zurich, CH
Philipp A. Kaufmann, M.D., Zurich, CH
Ulf Landmesser, M.D., Zurich, CH
Willibald Maier, M.D., Zurich, CH
Christian Matter, M.D., Zurich, CH
Georg Noll, M.D., Zurich, CH
Frank Ruschitzka, M.D., Zurich, CH
Christian Schmied, M.D., Zurich, CH
Rudolf Speich, M.D., Zurich, CH
Felix C. Tanner, M.D., Zurich, CH